DANIELLE STEFFAN: Open Payments
NPI 1568061794 · CAMBRIDGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,801 in 110 payments from 22 companies in 2025. Trend: 2023 $1,970 · 2024 $1,291 · 2025 $2,801
Food & beverage: $2,711Education: $90
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 25 | $641 |
| ABBVIE INC. | 33 | $583 |
| UCB, Inc. | 12 | $311 |
| Janssen Scientific Affairs, LLC | 3 | $204 |
| Ascendis Pharma Endocrinology Inc | 2 | $152 |
| Alexion Pharmaceuticals, Inc. | 3 | $150 |
| Janssen Biotech, Inc. | 5 | $135 |
| Mallinckrodt Hospital Products Inc. | 3 | $106 |
| Organon LLC | 3 | $73 |
| Fresenius Kabi USA, LLC | 3 | $68 |
Products named: RINVOQ, TREMFYA, Bimzelx, EVENITY, SKYRIZI, KRYSTEXXA, Yorvipath, OTEZLA.
Industry payments across MD — which companies pay providers there.
